Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who are being discharged from hospital after being admitted or seen urgently, where heart failure was either the main reason for the visit or a significant complication that made the stay longer
- Adults aged 18 or older who have been referred to a cardiology clinic for a first appointment within 1 week of a hospital or urgent care visit related to heart failure
- People whose heart's pumping strength (measured as ejection fraction) was found to be below 50% in the past 3 months
- People who had a specific blood test result (NT-proBNP above 900 pg/ml) either during the hospital stay or within 7 days after leaving the emergency department
- People who have a mailing address — either their own or a caregiver's
- People who are willing to give verbal consent to participate
Who may not be able to join:
- People who passed away or left hospital before being medically cleared for discharge
- People who are unable to assess or describe their own symptoms, such as those with clearly evident dementia
- People who are unable to use digital health technology or attend follow-up appointments
- People who have severe heart valve disease
- People who have already received, or are currently on a waiting list for, a mechanical heart pump (LVAD) or a heart transplant
- People who have complex heart conditions present from birth, a specific thickening of the heart muscle (hypertrophic obstructive cardiomyopathy), or a protein build-up condition affecting the heart (amyloid cardiomyopathy)
- People who have severe lung disease with breathlessness during minimal activity, a low lung function score (FEV1 below 1 litre), severely high blood pressure in the lung arteries, or who require oxygen at home
- People who have severe kidney disease, indicated by a persistently low kidney function score (eGFR below 30 mL/min/1.73m²)
- People who currently have an active cancer diagnosis
- People who are receiving palliative care or whose life expectancy is estimated to be less than 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Harriette Van Spall, MD, McMaster University
Phone: (905) 521-2100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary "Hierarchical" Composite Outcome of:; Co-primary "Hierarchical" Composite Outcome of:
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.